Expects 2025 revenue of approximately $1.9 billion (unaudited), $100 million above midpoint communicated on 3Q25 Earnings ...
Initiate Moderna with a Hold rating at a $25 target price (lower than the current price), citing balanced risk-reward despite the advanced mRNA platform and robust pipeline. MRNA's near-term execution ...
More than 46 million taxpayers claim the child tax credit each year, according to the Bipartisan Policy Center. The credit got a bump from the One Big Beautiful Bill, rising to $2,200 per eligible ...
Moderna MRNA announced that the Coalition for Epidemic Preparedness Innovations (“CEPI”) will invest up to $54.3 million in funding to support a pivotal phase III study evaluating its investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results